Nicholas Gulati
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Diphencyprone Plus Immune Checkpoint Inhibition in the Treatment of Cutaneous Metastases (NCT05481658) | Nicholas Gulati | 2022-10-06 |
| DPCP to Treat Cutaneous Neurofibromas Associated With NF1 (NCT05438290) | Nicholas Gulati | 2022-09-14 |
Track Nicholas Gulati automatically
Every clearance here is in the API, with alerts when new ones post.